EDGAR Filing Documents for 0001193125-17-095637

Form 8-K - Current report:

SEC Accession No. 0001193125-17-095637

Filing Date

2017-03-24

Accepted

2017-03-24 16:22:04

Documents

Period of Report

2017-03-23

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d334782d8k.htm	8-K	16586
2	EX-1.1	d334782dex11.htm	EX-1.1	211974
3	EX-5.1	d334782dex51.htm	EX-5.1	6805
4	GRAPHIC	g334782g49e64.jpg	GRAPHIC	8067
	Complete submission text file	0001193125-17-095637.txt		247719

Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030

Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100

BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 17713024
SIC: 2834 Pharmaceutical Preparations